Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1818498
Max Phase: Preclinical
Molecular Formula: C34H21Cl2F4N3O4
Molecular Weight: 682.46
Molecule Type: Small molecule
Associated Items:
ID: ALA1818498
Max Phase: Preclinical
Molecular Formula: C34H21Cl2F4N3O4
Molecular Weight: 682.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1O/C(=C\c2ccc(OCC(O)(Cn3cncn3)c3ccc(F)cc3F)cc2)C(c2ccc(F)cc2F)=C1c1ccc(Cl)c(Cl)c1
Standard InChI: InChI=1S/C34H21Cl2F4N3O4/c35-26-10-3-20(12-27(26)36)31-32(24-8-4-21(37)13-28(24)39)30(47-33(31)44)11-19-1-6-23(7-2-19)46-16-34(45,15-43-18-41-17-42-43)25-9-5-22(38)14-29(25)40/h1-14,17-18,45H,15-16H2/b30-11-
Standard InChI Key: SUWYCSWRIRASER-OHUIHDMLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 682.46 | Molecular Weight (Monoisotopic): 681.0845 | AlogP: 7.62 | #Rotatable Bonds: 9 |
Polar Surface Area: 86.47 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.44 | CX Basic pKa: 2.00 | CX LogP: 7.73 | CX LogD: 7.73 |
Aromatic Rings: 5 | Heavy Atoms: 47 | QED Weighted: 0.13 | Np Likeness Score: -0.57 |
1. Borate HB, Sawargave SP, Chavan SP, Chandavarkar MA, Iyer R, Tawte A, Rao D, Deore JV, Kudale AS, Mahajan PS, Kangire GS.. (2011) Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity., 21 (16): [PMID:21757344] [10.1016/j.bmcl.2011.06.022] |
Source(1):